Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 4/13/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Harry W. Wilcox III

Wrong Harry W. Wilcox III?

Chief Operating Officer and Gener...

Flagship Ventures
One Memorial Drive 7Th Floor
Cambridge , Massachusetts 02142
United States

Company Description: Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates through two synergistic units: VentureLabs™ which invents and launches...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • MBA
    Boston University School of Management
  • BS , finance
    University of Arizona
108 Total References
Web References
Celexion Team
www.celexionbio.com, 22 Mar 2015 [cached]
Harry Wilcox Director
Harry is currently Chief Financial Officer and Partner, Flagship Ventures, and brings to Celexion a rich set of experiences and expertise in financial management, operations, fund management and strategy. Harry joined Flagship Ventures in 2006, bringing a rich set of experiences and expertise in financial management, operations, fund management and strategy. His career spans 30 years and has involved many different roles and functions including Controller, CFO, Sr. VP BD, and CEO. He has also served on several Boards of Directors. In addition to his corporate experience, Harry was previously CFO of two venture capital firms, Highland Capital Partners where he was the founding CFO and General Partner, and prior to that, Charles River Ventures.
Most recently he has served as CFO and then Sr. VP Corporate Development for EXACT Sciences (NASDAQ:EXAS), one of Flagship's portfolio companies. In addition to EXACT Sciences, Harry led an active consulting practice which included roles as interim CEO of two biotech companies: Thrasos Therapeutics and Biostratum. Prior to this, Harry was Executive Vice President, Chief of Finance and Corporate Development of Pyrosequencing, a publicly-held European biotech company. Earlier, he had been the President and Chief Executive Officer of Cambridge NeuroScience, Inc. (NASDAQ:CNSI) until its sale to CeNeS Pharmaceuticals, and before that Sr. VP Business Development and CFO of Cellcor.
As COO and General Partner at Flagship Ventures, Harry is responsible for the operational management of Flagship's VentureLabsTM unit, serves as a member of Flagship's investment committee, and oversees the firm's financial operations and LP relations/fundraising. He was a board member of Accuri Cytometers prior to its successful sale to Becton Dickinson. He also plays a role as board member or advisor to select portfolio companies and is currently a board member of Black Duck, Celexion, Quantum Designs, Seahorse Bioscience, Selventa, Seventh Sense Biosystems, Tangent Medical Technologies, Inc. and T2 Biosystems.
Board of Directors - VisEn
www.visenmedical.com, 22 Mar 2009 [cached]
Harry Wilcox
Mr. Wilcox began working as an advisor to Visen in 2005 and joined the Board in 2007, bringing a rich set of experiences and expertise in financial management, operations, fund management and strategy. His career spans 28 years and has involved many different roles and functions and public and private companies in the life sciences space, including positions as CFO, Sr. VP BD, and CEO, at EXACT Sciences, Thrasos Therapeutics, and Pyrosequencing. He is currently CFO and Partner at Flagship Ventures. Mr. Wilcox has a deep background in the venture capital community, including tenures with Highland Capital Partners where he was the founding CFO and General Partner, and prior to that, Charles River Ventures.
Seventh Sense Biosystems :: Company
www.7sbio.com, 27 Jan 2015 [cached]
Harry Wilcox - Chief Operating Officer and General Partner, Flagship Ventures
Mr. Wilcox joined Flagship Ventures in 2006, bringing a rich set of experiences and expertise in financial management, operations, fund management and strategy. As COO and General Partner at Flagship Ventures, Mr. Wilcox oversees the firm's financial operations and LP relations/fundraising, and serves as board member or advisor to select portfolio companies. Mr. Wilcox is currently a board member of Black Duck, Celexion, Seahorse Bioscience, T2 Biosystems and Tangent Medical.
Mr. Wilcox's career spans 30 years and has involved many different roles and functions including Controller, CFO, Sr. VP BD, and CEO. He has also served on several Boards of Directors. Most recently he has served as CFO and then Sr. VP Corporate Development for EXACT Sciences (NASDAQ:EXAS), one of Flagship's portfolio companies, and on the Board of another portfolio company, Epitome Biosystems.
In addition to his corporate experience, Mr. Wilcox was previously CFO of two venture capital firms, Highland Capital Partners where he was the founding CFO and General Partner, and prior to that, Charles River Ventures. Mr. Wilcox has also led an active consulting practice, which included roles as interim CEO of biotech companies Thrasos Therapeutics and Biostratum. Mr. Wilcox earned a BS in finance from the University of Arizona and an MBA from Boston University School of Management.
Harry Wilcox | Flagship Ventures
www.flagshipventures.com, 22 Dec 2014 [cached]
Home > About > Flagship Team > Harry Wilcox
...
Harry Wilcox
...
Harry Wilcox
...
Harry Wilcox Chief Operating Officer and General Partner
Harry joined Flagship Ventures in 2006, bringing a rich set of experiences and expertise in financial management, operations, fund management and strategy. His career spans 30 years and has involved many different roles and functions including Controller, CFO, Sr. VP BD, and CEO. He has also served on several Boards of Directors. In addition to his corporate experience, Harry was previously CFO of two venture capital firms, Highland Capital Partners where he was the founding CFO and General Partner, and prior to that, Charles River Ventures.
Most recently he has served as CFO and then Sr. VP Corporate Development for EXACT Sciences (NASDAQ:EXAS), one of Flagship's portfolio companies. In addition to EXACT Sciences, Harry led an active consulting practice which included roles as interim CEO of two biotech companies: Thrasos Therapeutics and Biostratum. Prior to this, Harry was Executive Vice President, Chief of Finance and Corporate Development of Pyrosequencing, a publicly-held European biotech company. Earlier, he had been the President and Chief Executive Officer of Cambridge NeuroScience, Inc. (NASDAQ:CNSI) until its sale to CeNeS Pharmaceuticals, and before that Sr. VP Business Development and CFO of Cellcor.
As COO and General Partner at Flagship Ventures, Harry is responsible for the operational management of Flagship's VentureLabsTM unit, serves as a member of Flagship's investment committee, and oversees the firm's financial operations and LP relations/fundraising. He was a board member of Accuri Cytometers prior to its successful sale to Becton Dickinson. He also plays a role as board member or advisor to select portfolio companies and is currently a board member of Celexion, Quantum Designs, Seahorse Bioscience, Selventa, Seventh Sense Biosystems, Tangent Medical Technologies, Inc. and T2 Biosystems.
Board of Directors - Seahorse Bioscience
www.seahorsebio.com, 20 Dec 2014 [cached]
Harry Wilcox
Chief Financial Officer and Partner, Flagship Ventures
As CFO and Partner at Flagship Ventures, Harry manages all financial operations and LP relations/fundraising. Most recently, prior to joining Flagship Ventures, Harry served as CFO and then Sr. VP Corporate Development for EXACT Sciences. In addition to EXACT Sciences, during the last three years, Harry has led an active consulting practice which included roles as interim CEO of two biotech companies: Thrasos Therapeutics and Biostratum. Prior to this, Harry was Executive Vice President, Chief of Finance and Corporate Development of Pyrosequencing, a publicly-held biotech company.
Other People with the name "Wilcox":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304